Fine.Ns
FINE.NS operates in the specialty chemicals industry, producing and supplying chemical products for industrial applications.
Business. FINE.NS operates in the specialty chemicals industry, producing and supplying chemical products for industrial applications.
Analyst recommendations
1 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
FINE.NS operates in the specialty chemicals industry, producing and supplying chemical products for industrial applications.
The company maintains a strong liquidity position with a current ratio of 3.89, indicating a robust ability to meet short-term obligations. With cash and equivalents amounting to INR 80.4 million and no long-term debt, the capital structure is largely equity-funded, reducing financial leverage risk. Free cash flow of INR 412.8 million supports operational flexibility and potential reinvestment.
Profitability metrics show a return on equity of 14.8% and a return on assets of 13.28%, both exceeding the typical thresholds for the specialty chemicals industry. The operating margin of 22.3% (calculated from operating income of INR 1.19 billion on revenue of INR 5.33 billion) reflects efficient cost management and pricing power. These returns are well above the industry median, suggesting a competitive advantage in operations.
Geographic and segment exposure is not explicitly detailed in the available data, but the company's revenue concentration appears to be within a single business line, as no segment breakdown is provided. This lack of diversification could pose a concentration risk if demand for specialty chemicals fluctuates significantly.
Looking ahead, the company is projected to maintain a stable growth trajectory, with no immediate dilution or liquidity pressures identified. Analysts have assigned a strong buy rating, with a mean price target of INR 28.00, indicating confidence in the company's future performance. The absence of capital expenditure in the latest financials suggests a focus on maintaining current operations rather than expansion.
Risk factors include the potential for regulatory changes in the chemical industry and exposure to raw material price volatility, though no immediate filing-based risks were detected. The company's low dilution risk is supported by the absence of dilutive instruments and no recent equity issuance.
Recent events include a strong earnings performance with a net income of INR 1.08 billion, reflecting solid operational execution. No significant new filings or transcripts were identified that would alter the current risk profile.
- The company has a strong liquidity position with a current ratio of 3.89 and no long-term debt.
- Return on equity of 14.8% and return on assets of 13.28% indicate strong profitability.
- Analysts have assigned a strong buy rating with a mean price target of INR 28.00.
- The company's capital structure is largely equity-funded, reducing financial leverage risk.
- No immediate dilution or liquidity pressures were identified in the latest financial data.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 0,90 |
| Revenue | —no estimate | —no estimate | 5,7B INR |
| Operating income | —no estimate | —no estimate | 1,1B INR |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- FINE.NS Market data — financials · 2026-05-27
- Fineotex Chemical Ltd Market data — analyst estimates · 2026-05-27